Target
Egl nine homolog 1 [179-426]
Ligand
BDBM107707
Substrate
n/a
Meas. Tech.
EGLN-1 Activity Assay
IC50
440±n/a nM
Citation
 Kawamoto, RMWu, SEvdokimov, AGGreis, KDBoyer, ASWarshakoon, NC Prolyl hydroxylase inhibitors and methods of use US Patent  US11426393 Publication Date 8/30/2022 
Target
Name:
Egl nine homolog 1 [179-426]
Synonyms:
C1orf12 | EGLN1 | EGLN1_HUMAN | Hypoxia-inducible factor prolyl hydroxylase 2 (HIFPH2)
Type:
n/a
Mol. Mass.:
27759.84
Organism:
Homo sapiens (Human)
Description:
EGLN-1-179/426
Residue:
248
Sequence:
LRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF
  
Inhibitor
Name:
BDBM107707
Synonyms:
US11426393, Compound Table XV.13 | US8598210, Table XV, 13 | US8722895, 13: {[5-(4-Isopropylphenyl)-3-hydroxypyridine- 2-carbonyl]amino}-acetic acid | US9598370, Example 00138 | USRE47437, Example {[5-(4-Isopropylphenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid
Type:
Small organic molecule
Emp. Form.:
C17H18N2O4
Mol. Mass.:
314.3358
SMILES:
CC(C)c1ccc(cc1)-c1cnc(C(=O)NCC(O)=O)c(O)c1
Structure:
Search PDB for entries with ligand similarity: